Medtech Trendwatch: For Experts By Experts
-
Value-Based Tech And Changing Patient Demographics: The Dental Device Market’s Future
6/7/2016
The dental medical device industry is shifting due to changes in regulatory factors, demographics, and economics. These shifts ripple outward to affect the patients, the dentists, and ultimately the manufacturers of dental medical devices, in a way that is causing major changes in the competitive landscape.
-
China’s Diagnostic Imaging System Market: Foreign Vendor Opportunities & Challenges
5/12/2016
The first part of this article examined how China’s healthcare reform, within the context of the 13th Five-Year Plan, affected Chinese diagnostic imaging vendors. Here, we examine the role of foreign manufacturers, as well as the challenges and opportunities they face.
-
China’s Diagnostic Imaging System Market: Healthcare Reform & Domestic Companies’ Advantage
5/9/2016
China's course toward national development has placed healthcare reform front and center. An expanding middle class — with expanding global connectivity — is increasingly demanding congruency with Western healthcare standards. This two-part article outlines key challenges and opportunities resultant of China’s 13th Five-Year Plan and healthcare reform, starting with a look at domestic systems' place in the imaging market.
-
A Comprehensive Guide To The U.S. TAVR Market: Looking Ahead
4/18/2016
The second article in a two-part series examining the past, present, and future of the U.S. transcatheter aortic valve replacement (TAVR) market, this installment examines what it will take for TAVRs to become the standard of care for low-, intermediate-, and high-risk patients with severe symptomatic aortic stenosis. It also looks at major competitors in the space and emerging opportunities.
-
A Comprehensive Guide To The U.S. TAVR Market: Surveying The Field
4/12/2016
Transcatheter aortic valve replacement (TAVR) is showing hints that it could one day supplant surgical AVR as the standard of care for all patients with severe aortic stenosis (AS). In part one of this two-part series, we'll examine how the TAVR market has evolved and the impact of the recently completed PARTNER 2 studies on its future.
-
How Product Innovation Is Revitalizing Pacemaker Markets
3/10/2016
Even in mature device markets, innovation can change commonly held conceptions of a market’s destiny. Creating and understanding a theoretical alternate timeline helps to quantify the value of such innovation.
-
OEMs Vs. Third-Party Providers: Conquering The U.S. Endoscope Service Market
2/11/2016
Third-party providers currently service almost one-third of all endoscopes and generate about 20 percent of the revenues in this space, exerting tremendous competitive pressure on OEMs. Here's a look at how third-party providers are getting a leg up, as well as steps OEMs can take to retain - and even grow - their market share.
-
Going GLocal: MedTech Strategies For Emerging Economies
12/10/2015
For medtech companies to succeed in emerging economies, one strategy is to go “GLocal” — to remain global in vision, yet customize offerings according to specific unmet needs of customers in those markets. This strategy requires companies to make strategic decisions on frugal innovation and to create marketing plans for emerging economies.
-
Financial And Regulatory Trends In China — And Their Implications For Med Device Companies
9/30/2015
China has experienced a strong economic boom in the past 10 years, and many industries in China have benefited as a consequence. The medical device industry in China is no exception, growing at an average rate of 20 percent annually since 2009, and it is expected to reach almost RMB $300 billion (USD $45 billion) this year. However, China’s economy is expected to experience its first downturn in a number of years. We will discuss how this and other recent trends may affect the medical device industry in China, both now and in the future.
-
Medtech M&A: FTC’s Changing Mandate And Its Impact On The Industry
7/10/2015
Medical device companies pursue acquisitions to consolidate their positions in the market, realize revenue synergies, and establish economies of scale. Recently, the medical device landscape in the U.S. has been marked by a never-before-seen flurry of mergers-and-acquisitions activity. But this heightened M&A activity has brought with it increased scrutiny from regulatory agencies, particularly the Federal Trade Commission (FTC).